FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048656760> ?p ?o ?g. }

• W3048656760 endingPage "2157" @default.
• W3048656760 startingPage "2147" @default.
• W3048656760 abstract "Triple-negative breast cancer (TNBC) is an immune-enriched subset of breast cancer that has recently demonstrated clinical responsiveness to combinatorial immunotherapy. However, the lack of targeted interventions against hormone receptors or HER2 continues to limit treatment options for these patients. To begin expanding available interventions for patients with metastatic TNBC, we previously reported a therapeutic vaccine regimen that significantly reduced spontaneous lung metastases in a preclinical TNBC model. This heterologous vaccine approach “primed” mice with tumor lysate antigens encapsulated within poly(lactic-co-glycolic) acid microparticles (PLGA MPs), and then “boosted” mice with tumor lysates plus adjuvant. The use of the PLGA MP prime as monotherapy demonstrated no efficacy, suggesting that improving this component of our therapy would achieve greater vaccine efficacy. Here, we functionally improved the PLGA MP prime by coating microparticles with biotinylated streptavidin-conjugated using 1-ethyl-3-(3-dimethylaminoproplyl) carbodiimide/N-hydroxysuccinimide (EDC/Sulfo-NHS) linkers. This modification enhanced the immunostimulatory potential of our PLGA MPs, as evidenced by increased phagocytosis, maturation, and stimulatory ligand expression by antigen-presenting cells (APCs). Therapeutic prime/boost vaccination of TNBC-bearing mice with surfaced-coated PLGA MPs significantly reduced spontaneous lung metastases by an average of 56% relative to mice primed with unmodified PLGA MPs, and a significant 88% average reduction in spontaneous lung metastases relative to untreated control mice. These findings illustrate that relatively common biotin–streptavidin conjugation formulations can positively affect microparticle-based vaccine immunogenicity resulting in enhanced therapeutic efficacy against established preclinical mammary tumors." @default.
• W3048656760 created "2020-08-18" @default.
• W3048656760 creator A5002551319 @default.
• W3048656760 creator A5004594443 @default.
• W3048656760 creator A5048508614 @default.
• W3048656760 creator A5063163547 @default.
• W3048656760 creator A5064722874 @default.
• W3048656760 creator A5065395162 @default.
• W3048656760 date "2020-08-12" @default.
• W3048656760 modified "2023-09-25" @default.
• W3048656760 title "Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine" @default.
• W3048656760 cites W1978494950 @default.
• W3048656760 cites W1983109868 @default.
• W3048656760 cites W1994815971 @default.
• W3048656760 cites W2009720434 @default.
• W3048656760 cites W2017390384 @default.
• W3048656760 cites W2039261563 @default.
• W3048656760 cites W2039938599 @default.
• W3048656760 cites W2043450052 @default.
• W3048656760 cites W2051654117 @default.
• W3048656760 cites W2058120775 @default.
• W3048656760 cites W2062197511 @default.
• W3048656760 cites W2071327437 @default.
• W3048656760 cites W2076144848 @default.
• W3048656760 cites W2088005931 @default.
• W3048656760 cites W2089618836 @default.
• W3048656760 cites W2102718441 @default.
• W3048656760 cites W2105838733 @default.
• W3048656760 cites W2127486425 @default.
• W3048656760 cites W2131423491 @default.
• W3048656760 cites W2155240407 @default.
• W3048656760 cites W2269881068 @default.
• W3048656760 cites W2345478270 @default.
• W3048656760 cites W2395900286 @default.
• W3048656760 cites W2523350566 @default.
• W3048656760 cites W2529188071 @default.
• W3048656760 cites W2583734028 @default.
• W3048656760 cites W2593030814 @default.
• W3048656760 cites W2597537649 @default.
• W3048656760 cites W2604024577 @default.
• W3048656760 cites W2618210811 @default.
• W3048656760 cites W2621295461 @default.
• W3048656760 cites W2724264513 @default.
• W3048656760 cites W2728365508 @default.
• W3048656760 cites W2745547213 @default.
• W3048656760 cites W2755360248 @default.
• W3048656760 cites W2765869937 @default.
• W3048656760 cites W2766581433 @default.
• W3048656760 cites W2781525129 @default.
• W3048656760 cites W2797967795 @default.
• W3048656760 cites W2885587871 @default.
• W3048656760 cites W2890342126 @default.
• W3048656760 cites W2897422388 @default.
• W3048656760 cites W2911757002 @default.
• W3048656760 cites W2931604048 @default.
• W3048656760 cites W2983666708 @default.
• W3048656760 cites W4245248161 @default.
• W3048656760 cites W4252714226 @default.
• W3048656760 doi "https://doi.org/10.1021/acs.bioconjchem.0c00347" @default.
• W3048656760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32786363" @default.
• W3048656760 hasPublicationYear "2020" @default.
• W3048656760 type Work @default.
• W3048656760 sameAs 3048656760 @default.
• W3048656760 citedByCount "10" @default.
• W3048656760 countsByYear W30486567602021 @default.
• W3048656760 countsByYear W30486567602022 @default.
• W3048656760 countsByYear W30486567602023 @default.
• W3048656760 crossrefType "journal-article" @default.
• W3048656760 hasAuthorship W3048656760A5002551319 @default.
• W3048656760 hasAuthorship W3048656760A5004594443 @default.
• W3048656760 hasAuthorship W3048656760A5048508614 @default.
• W3048656760 hasAuthorship W3048656760A5063163547 @default.
• W3048656760 hasAuthorship W3048656760A5064722874 @default.
• W3048656760 hasAuthorship W3048656760A5065395162 @default.
• W3048656760 hasConcept C121608353 @default.
• W3048656760 hasConcept C126322002 @default.
• W3048656760 hasConcept C147483822 @default.
• W3048656760 hasConcept C185592680 @default.
• W3048656760 hasConcept C202751555 @default.
• W3048656760 hasConcept C203014093 @default.
• W3048656760 hasConcept C204628709 @default.
• W3048656760 hasConcept C2775930923 @default.
• W3048656760 hasConcept C2775997276 @default.
• W3048656760 hasConcept C2776190903 @default.
• W3048656760 hasConcept C2777521759 @default.
• W3048656760 hasConcept C2777701055 @default.
• W3048656760 hasConcept C2777863537 @default.
• W3048656760 hasConcept C2778204606 @default.
• W3048656760 hasConcept C2780165375 @default.
• W3048656760 hasConcept C2780868878 @default.
• W3048656760 hasConcept C502942594 @default.
• W3048656760 hasConcept C530470458 @default.
• W3048656760 hasConcept C55493867 @default.
• W3048656760 hasConcept C71924100 @default.
• W3048656760 hasConcept C86803240 @default.
• W3048656760 hasConcept C87355193 @default.
• W3048656760 hasConcept C8891405 @default.
• W3048656760 hasConcept C98274493 @default.

• next